Abstract: The invention provides a dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity and a complementary or non-complementary immunoglobulin variable domain having a second binding specificity.

Abstract: Improved anti-CD154 antibodies are provided herein which have ablated FcR binding and/or complement binding/activation. The use of these antibodies for inducing tolerance and treating immune diseases including autoimmunity, inflammation and allergic disorders is disclosed herein.

Abstract: This disclosure provides antibodies that are useful for preventing and/or treating malaria. The epitope to which the antibodies bind is in close proximity to the conserved proteolytic cleavage site of P. falciparum circumsporozoite protein (CSP), and the antibodies provided in this disclosure can prevent cleavage and inhibit P. falciparum sporozoites from invading the liver.

Abstract: The present invention is directed to isolated polypeptides and antibodies suitable for producing therapeutic preparations, methods, and kits relating to bone deposition. One objective of the present invention is to provide compositions that improve bone deposition. Yet another objective of the present invention is to provide methods and compositions to be utilized in diagnosing bone dysregulation. The therapeutic compositions and methods of the present invention are related to the regulation of Wise, Sost, and closely related sequences. In particular, the nucleic acid sequences and polypeptides include Wise and Sost as well as a family of molecules that express a cysteine knot polypeptide.

Abstract: The present invention relates to anti-TNF antibodies comprising all of the heavy chain variable CDR regions of SEQ ID NOS: 1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein or fragment thereof, as well as nucleic acids encoding such anti-TNF antibodies, complementary nucleic acids, vectors, host cells, production methods and therapeutic methods.

Abstract: The present invention provides a method for the treatment and/or prophylaxis of glomerulonephritis associated with one or more disorders selected from the group consisting of Goodpasture's syndrome, a vasculitic disorder, Wegener's disease, IgA nephropathy and an inflammatory disease with basement membrane involvement comprising administering a therapeutically effective amount of agent which interacts with or modulates the expression or activity of a mammalian IL-6 polypeptide.

Abstract: The invention relates to a method of inhibiting chemotherapy induced upregulation of Cathepsin S on the surface of tumor cells, the method comprising the administration of a Cathepsin S inhibitor to said cells. Also provided is a therapy comprising an anti Cathepsin S antibody, in particular an anti-Cathepsin S antibody which does not inhibit the proteolytic effect of Cathepsin S but nevertheless inhibits angiogenesis and a combination treatment comprising a Cathepsin S inhibitor and a therapeutic agent.

Abstract: Recombinant materials and methods for producing antibodies that specifically bind heregulin-coupled HER3, at a site distinct from the heregulin binding site, are described. These antibodies are particularly useful in treating cancer that expresses HER3.

Abstract: This invention provides binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind a CD154 (CD40L) protein. This invention also provides a chimeric, humanized or fully human antibody, antibody derivative or antibody fragment that specifically binds to an epitope to which a humanized Fab fragment comprising a variable heavy chain sequence according to SEQ ID NO: 1 and comprising a variable light chain sequence according to SEQ ID NO: 2 specifically binds. CD154 binding proteins of this invention may elicit reduced effector function relative to a second anti-CD154 antibody. CD154 binding proteins of this invention are useful in diagnostic and therapeutic methods, such as in the treatment and prevention of diseases including those that involve undesirable immune responses that are mediated by CD154-CD40 interactions.

Abstract: The present invention relates to novel humanised antibodies against human CD52 and their use in methods of treating or preventing human diseases.

Abstract: The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLDN6, including tumor-related diseases such as ovarian cancer, lung cancer, gastric cancer, breast cancer, hepatic cancer, pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, sarcoma, bile duct cancer, cancer of the urinary bladder, kidney cancer, colon cancer, placental choriocarcinoma, cervical cancer, testicular cancer, and uterine cancer.

Abstract: The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.

Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.

Abstract: We provide an antibody capable of binding to an intracellular PRL-I or PRL-3 polypeptide, in which the antibody is capable of binding to an epitope bound by antibody 269, antibody 223 or antibody 318. Such anti-PRL antibodies may be capable of binding to intracellular PRL-I or PRL-3. They may be suitable for use as therapies against cancer or metastasis thereof, or in clinical diagnosis to identify PRL-3 or PRL-I positive patients.

Abstract: Compositions and methods comprising proteins that bind specifically to adalimumab are disclosed herein. Adalimumab is a monoclonal antibody specific for the cytokine TNF-? and was developed to treat TNF-? mediated inflammatory diseases. In one aspect of the instant invention, the binding proteins are antibodies directed toward adalimumab. These antibodies, including binding fragments thereof, can be used in a clinical setting as well as for research and development. For example, these anti-adalimumab antibodies can be employed to neutralize adalimumab.

Abstract: The present invention relates to activatable toxin complexes which include a cleavable inhibitory peptide. More specifically, the complexes comprise a cell targeting domain, a toxin catalytic domain, a specific protease cleavage site and an inhibitory peptide domain. The inhibitory peptide prevents the catalytic domain from exerting toxic effects until its release from the complex by the action of a protease, such a viral protease, at the protease cleavage site. Further provided are pharmaceutical compositions comprising the complexes and use thereof for treating infections and malignant disease.

Abstract: The present invention relates to a method for preventing the unfolding of a (poly)peptide during drying and/or inducing the (re-)folding of a (poly)peptide after drying, comprising the step of embedding the (poly)peptide in an aqueous solution, wherein the solution comprises (i) at least three different amino acids; or (ii) at least one dipeptide or tripeptide; and wherein the solution is free or substantially free of (a) sugar; and (b-i) protein; and/or (b-ii) denaturing compounds; and (c) silanes.

Abstract: The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence.

Abstract: Methods are provided for reducing one or more dimensions of individual pieces of biomass; treating biomass, such as size-reduced biomass; changing a molecular structure of a biomass material; and, optionally, subjecting the biomass to a primary process to form a product. The methods include processing biomass materials using a screw extrusion process, and treating the biomass material with a screw extrusion process in size-reduction and treating steps.

Abstract: The present invention relates generally to water soluble polymer powder formulations, and more particularly, to a cellulose ether formulation which in powder form is suitable for direct addition to water-based systems to produce smooth, lump free solutions. The cellulose ethers are crosslinked with an aldehyde crosslinker and include a dry weak acid which slows hydrolysis of the hermiacetal linkage formed by the crosslinker. The selected acid does not adversely affect solubility stability.

Abstract: Polysaccharide derivatives, more particularly heteropolysaccharide derivatives, especially hemicellulose derivatives, methods for making same and structures employing same are provided.

Abstract: A photoinitiator composition comprising a combination of aminoalkyl phenone, thioxanthone and multifunctional amino benzoate synergist for use in printing inks and coatings that are curable using UV radiation, particularly from LED lamps.

Abstract: This invention relates to organoaluminum compounds, to organoaluminum activator systems, preferably supported, to polymerization catalyst systems containing these activator systems and to polymerization processes utilizing the same. In particular, this invention relates to catalyst systems comprising an ion-exchange layered silicate, an organoaluminum compound, and a metallocene.

Abstract: In a method for producing a water absorbent resin by drying a particulate hydrogel having a high solid content concentration (of 45% by weight or more, preferably 50% by weight or more, and more preferably 55% by weight or more), a method for efficient drying water absorbent resin having maintained/improved physical properties is provided.

Abstract: This invention relates to a process to produce a functionalized polymer comprising: a) contacting an iodine modified aromatic polymer with an oxidizing agent to obtain an iodonium salt of the aromatic polymer; b) contacting the iodonium salt of the aromatic polymer with a polymer having internal or terminal unsaturation(s); and c) obtaining a functionalized polymer from the polymer having internal or terminal unsaturation(s) wherein the functionalized polymer has an Mn less than the Mn of the polymer having internal or terminal unsaturation(s) and the functionalized polymer has an acid number higher than the acid number of the polymer having internal or terminal unsaturation(s).

Abstract: A spheric magnesium compound comprises a reaction product of at least the following components: (a) a magnesium halide having a formula of MgX2-nRn, wherein X is independently chloride or bromide, R is a C1-C14 alkyl, a C6-C14 aryl, a C1-C14 alkoxy, or a C6-C14 aryloxy, and n is 0 or 1; (b) an alcohol compound; and (c) an epoxy compound having a general formula (I), wherein R2 and R3 are independently hydrogen, a C1-C5 linear or branched alkyl, or a C1-C5 linear or branched haloalkyl. The magnesium compound has characteristic DSC curve and X-ray diffraction pattern, and can be used as a carrier for olefin polymerization catalyst. stereoregularity of polymer having high melt index, and low content of polymer fines.

Abstract: Disclosed are new classes of pyridyldiamide catalyst components useful in olefin polymerization, an example of which includes: wherein M is a hafnium or zirconium; R1 and R11 are selected from phenyl and substituted phenyl, wherein the substitutions are selected from C1 to C5 hydrocarbyls, preferably C2 to C4 hydrocarbyls, and can reside in any of the ortho, meta, para positions on the phenyl ring; R2? and R2? are selected independently from hydrogen and C1 to C6 hydrocarbyls, preferably hydrogen; R10 is a hydrocarbyl bridging group; R3, R4, and R5 are independently selected from hydrogen, hydrocarbyls, and substituted hydrocarbyls; and R6, R7, R8, and R9 are independently selected from hydrogen, hydrocarbyls, and substituted hydrocarbyls; wherein R6 and R7 form an aromatic ring or R7 is hydrogen and R6 is selected from methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, and tert-butyl, preferably methyl.

Abstract: Olefin polymerization is carried out with a supported phosphinimine catalyst which has been treated with a long chain substituted amine compound.

Abstract: A thermoplastic resin has excellent heat resistance and thermal stability, low water absorption properties, excellent surface hardness and mechanical strength. A thermoplastic resin includes a constituent unit (a) that is derived from a (meth)acrylate monomer and represented by the formula (1); a constituent unit (b) that is derived from a vinyl monomer and represented by the formula (2); and a constituent unit (c) that is derived from a vinyl monomer and represented by the formula (3), and the weight percentage of the constituent unit (a), based on the total weight of the all constituent units, is 60 to 85% by weight, the weight percentage of the constituent unit (b), based on the total weight of the all constituent units, is 5 to 30% by weight, and the weight percentage of the constituent unit (c), based on the total weight of the all constituent units, is 5 to 15% by weight.

Abstract: This invention pertains to an azo-crosslinked fluoropolymer with perfluoroether pendant groups. The polymer so formed is highly useful in the form of shaped articles with excellent chemical and thermal stability, including photoimaged coatings. The azo-crosslinked fluoropolymer hereof is advantageously formed by exposure to UV radiation of a fluorinated polymer having dichloroamino-functionalized perfluoroether pendant groups. In one embodiment, a fluorinated polymer having dichloroamino-functionalized perfluoroether pendant groups is formed into a shaped article that is then UV-treated in situ.

Abstract: There is provided provide a photosensitive resin composition which can markedly improve transparency, heat resistance, heat discoloration resistance, solvent resistance, and patterning properties. A photosensitive resin composition including: a polymer (A) in which a content of a unit structure containing a boronic acid group, a unit structure containing a boronic acid ester group, or a combination of these unit structures is 20 mol % to 100 mol % of a total molar number of unit structures constituting the polymer; and a photosensitizer (B). The polymer (A) preferably has a weight average molecular weight of 1,000 to 50,000. A cured film obtained from the photosensitive resin composition. A microlens prepared from the photosensitive resin composition.

Abstract: The present invention relates to polyvinyl sulfonic acid comprising a vinyl sulfonic acid unit represented by a specific general formula (1), wherein the molar amount of sulfonic acid groups derived from vinyl sulfonic acid monomers with respect to the molar amount of total monomer units is 50.0 to 98.0 mol %, and the polyvinyl sulfonic acid has an absorbance of 0.1 or greater (aqueous solution: 0.2 mass %, cell length: 10 mm) in a wavelength range of 255 to 800 nm.

Abstract: The present invention relates to a catalyst composition for the polymerisation of olefins comprising a support containing a single site catalyst component, a catalyst activator and a modifier wherein the modifier is the product of reacting an aluminum compound of general formula AI(R1, R2, R3) with an amine compound of general formula N(R4, R5, R6). The catalyst composition reduces fouling and/or sheeting when used to catalyse the polymerisation of olefins. The present invention also relates to a method for the polymerisation of olefins using the catalyst composition of the invention.

Abstract: Resins suitable for rotomolded articles comprise a bimodal polyethylene copolymer comprising from 0.1 to 5 weight % of one or more C6-8 alpha olefins and the balance ethylene, comprising from 20 to 50 weight % of a higher molecular weight polymer component having an Mw greater than 120,000 and correspondingly from 80 to 50 weight % of a lower molecular weight polymer component having an Mw less than 100,000 having a density greater than 0.942 g/cc [but less than 0.965 g/cc] and a bent strip ESCR as determined by ASTM D 1693 in 100% Igepal® CO-630 (ethoxylated nonylphenols) for conditions A and B of greater than 1000 hours. The resulting articles have a very good balance of properties and significant ESCR.

Abstract: The present disclosure relates to the novel multistep procedure for preparation of polymer monoliths for use in solvent exchange, such as methods to exchange and activate fluoride ions on a flow through microfluidic chip for subsequent chemical synthesis. Methods according to the present disclosure include the application of such microfluidic platforms for rapid F18 radiosynthesis on a flow through microfluidic chip with high efficiency, followed by a subsequent nucleophilic fluorination reaction. Various other methods of exchanging and activating fluoride ions on a flow through microfluidic chip are also disclosed. Methods incorporating features of the present invention can be applicable to any flow through microfluidic device in any field, such as radiosyntheses, chemical syntheses, concentration of ions for environmental analyzes and sample preparation such as concentrating minute amounts of analyte to improve the downstream detection.

Abstract: In accordance with the present invention, aqueous emulsion polymerization processes of synthesizing 2,3,3,3-tetrafluoropropene/vinylidene fluoride copolymers having 2,3,3,3-tetrafluoropropene as the major monomer unit are provided.

Abstract: Products and processes relating to the synthesis of copolymers or terpolymers are described. In particular, poly(acrylic acid-co-acrylate ester), poly(methacrylic acid-co-methacrylate ester), poly(acrylic acid-co-acrylate ester(I)-co-acrylate ester(II)), or poly(methacrylic acid-co-methacrylate ester(I)-co-methacrylate ester(II)), by esterification of polyacrylic or polymethacrylic acid with alcohols assisted by the pervaporation technique for extracting water are described.

Abstract: New water soluble cationic copolymers derived from N-vinyl amide monomers and ethylenically unsaturated compounds bearing cationic groups.

Abstract: To provide a novel diisopropyl fumarate-cinnamic acid derivative-based copolymer expected to be formed into a retardation film having excellent optical properties ensuring that, for example, the refractive index in the film thickness direction and the out-of-plane retardation are large and even in the form of a thin film, the film has a high out-of-plane retardation, and a retardation film using the same. The diisopropyl fumarate-cinnamic acid derivative-based copolymer contains: a diisopropyl fumarate residue unit; and a cinnamic acid residue unit or a cinnamic acid ester residue unit having an alkyl group with a carbon number of 1 to 6.

Abstract: A water-insoluble copolymer including an epoxide containing structural unit represented by Formula (I), wherein: the epoxide containing group is positioned meta, ortho or para on the ring relative to the bond linkage with the polymer backbone; L is an optional linking group; and R1, R2 and R3 are independently selected from: hydrogen, or a substituted or unsubstituted hydrocarbyl group.

Abstract: The present invention aims to provide a surface modification method for a rubber vulcanizate or a thermoplastic elastomer, which can impart various functions such as sliding properties and biocompatibility according to its use. The present invention relates to a surface modification method for modifying a rubber vulcanizate or a thermoplastic elastomer as an object to be modified, the method including: Step 1 of forming polymerization initiation points on a surface of the object to be modified; Step 2 of radical polymerizing monomers starting from the polymerization initiation points to grow polymer chains on the surface of the object to be modified; and Step 3 of functionalizing the polymer chains.

Abstract: A personal care composition includes a hybrid copolymer including at least one ethylenically unsaturated monomer and a naturally derived hydroxyl containing chain transfer agent as an end group, a hybrid synthetic copolymer including one or more synthetic polymers derived from the at least one ethylenically unsaturated monomer with at least one initiator fragment as an end group and an effective amount of a cosmetic or personal care additive.

Abstract: A hydrogenated block copolymer having two or more polymer blocks (a) each with a structural unit derived from an aromatic vinyl compound and one or more polymer blocks (b) each with structural units derived from isoprene and 1,3-butadiene, the hydrogenated block copolymer having a crystallization peak temperature of ?3 to 15° C.

Abstract: Provided are an additive for resist represented by the following formula (1), and a resist composition containing the additive. The additive according to the present invention can suppress leaching caused by water during an immersion lithographic process by increasing hydrophobicity of the surface of the resist film in the exposure at the time of applying the additive to a resist composition, and can form a fine resist pattern having excellent sensitivity and resolution at the time of applying the additive to a resist composition. wherein the substituents respectively have the same meanings as defined above.

Abstract: The present invention relates to a process for producing porous materials, which comprises reaction of at least one polyfunctional isocyanate with at least one polyfunctional aromatic amine in the presence of at least one catalyst and a solvent. The invention further relates to the porous materials which can be obtained in this way and the use of the porous materials as insulation material, in particular for applications in the building sector and in vacuum insulation panels.

Abstract: Plasticizer free curing compositions comprising small particle size complexes of methylenedianiline and an alkali salt, e.g. a 3:1 coordination complex of MDA/alkali salt, with average diameter 60 micron or less, often 20 micron or less, e.g., 10 microns or less, dispersed in a volatile, non-polar, organic solvent are prepared. Stable one pack urethane compositions comprising the plasticizer free curing compositions and polyurethane prepolymers are prepared, which exhibit excellent storage stability and overcome many of the drawbacks encountered when using MDA complexes dispersed in plasticizers such as high boiling aromatic and alkyl di-esters.

Abstract: The present invention relates to a process for preparing silylated polyurethane polymers which have increased stability under ambient condition or storage toward atmospheric moisture, in the presence of at least one of titanium-containing catalyst or zirconium-containing catalyst and to silylated polyurethane polymer compositions comprising these catalysts.

Abstract: The invention relates to novel processes for controlling (extending) the pot life in polyurethane (PU) based systems that are chain-extended with diamines, preferably PU elastomers, PU adhesives, PU casting resins.

Abstract: A two-component curable epoxy resin system is disclosed. The resin system includes an epoxy resin component containing at least 80% by weight of a polyglycidyl ether of a polyphenol. The system also includes an hardener mixture containing mainly polyethylene tetraamines. The system include triethylene diamine in specific amounts as a catalyst. The system has beneficial curing characteristics that make it useful for producing fiber-reinforced composites in a resin transfer molding process.

Abstract: A liquid methylenedianiline product is disclosed. The product is produced by reacting aniline and ethylaniline with formaldehyde with an amine to formaldehyde ratio greater than about 2:1. The resulting reaction product is a liquid mixture of methylenedianiline, monoethyl methylenedianiline, and diethyl methylenedianiline having a viscosity of less than about 1000 cps at 40° C.